$0.6409
-0.0165[-2.51%]
At close: Apr 25
$0.6409
0[0.00%]
After Hours: 4:10PM EDT
Evogene reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Evogene using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/16/2024 | AM | EVGN | Q1 | -$0.15 | -$0.09 | — | — | $641.00K | $3.50M | — | — | Get Alert |
03/07/2024 | AM | EVGN | Q4 | -$0.07 | -$0.14 | -$0.13 | 7.14% | $660.00K | $910.00K | $578.00K | -36.48% | Get Alert |
11/15/2023 | AM | EVGN | Q3 | -$0.16 | -$0.16 | -$0.08 | 50.00% | $466.00K | $1.18M | $3.77M | 219.24% | Get Alert |
08/17/2023 | AM | EVGN | Q2 | -$0.21 | -$0.17 | -$0.17 | 0.00% | $312.00K | $880.00K | $654.00K | -25.68% | Get Alert |
05/18/2023 | AM | EVGN | Q1 | -$0.20 | -$0.16 | -$0.15 | 6.25% | $237.00K | $870.00K | $641.00K | -26.32% | Get Alert |
03/09/2023 | AM | EVGN | Q4 | -$0.18 | -$0.20 | -$0.07 | 65.00% | $311.00K | $420.00K | $660.00K | 57.14% | Get Alert |
11/17/2022 | AM | EVGN | Q3 | -$0.19 | -$0.20 | -$0.16 | 20.00% | $151.00K | $100.00K | $466.00K | 366.00% | Get Alert |
08/31/2022 | AM | EVGN | Q2 | -$0.15 | -$0.17 | -$0.21 | -23.53% | $135.00K | $270.00K | $312.00K | 15.56% | Get Alert |
05/26/2022 | AM | EVGN | Q1 | -$0.17 | — | -$0.20 | — | $333.00K | — | $237.00K | — | Get Alert |
03/10/2022 | AM | EVGN | Q4 | -$0.25 | -$0.17 | -$0.18 | -5.88% | $351.00K | $270.00K | $311.00K | 15.19% | Get Alert |
11/17/2021 | AM | EVGN | Q3 | -$0.17 | -$0.17 | -$0.19 | -11.76% | $316.00K | $270.00K | $151.00K | -44.07% | Get Alert |
08/11/2021 | AM | EVGN | Q2 | -$0.16 | -$0.18 | -$0.15 | 16.67% | $298.00K | $300.00K | $135.00K | -55.00% | Get Alert |
05/26/2021 | AM | EVGN | Q1 | -$0.24 | — | -$0.17 | — | $75.00K | $300.00K | $333.00K | 11.00% | Get Alert |
03/03/2021 | AM | EVGN | Q4 | -$0.24 | — | -$0.25 | — | $116.00K | — | $351.00K | — | Get Alert |
11/18/2020 | AM | EVGN | Q3 | -$0.16 | — | -$0.17 | — | $97.00K | $1.90M | $316.00K | -83.37% | Get Alert |
08/05/2020 | AM | EVGN | Q2 | -$0.16 | — | -$0.16 | — | $192.00K | $1.90M | $298.00K | -84.32% | Get Alert |
05/26/2020 | AM | EVGN | Q1 | -$0.15 | — | -$0.24 | — | $348.00K | $1.90M | $75.00K | -96.05% | Get Alert |
03/04/2020 | AM | EVGN | Q4 | -$0.23 | — | -$0.24 | — | $635.00K | $1.90M | $116.00K | -93.89% | Get Alert |
11/13/2019 | AM | EVGN | Q3 | -$0.19 | — | -$0.16 | — | $367.00K | — | $97.00K | — | Get Alert |
Evogene (EVGN) is scheduled to report earnings on May 16, 2024. The last reported earnings were for reported on March 7, 2024 for Q4.
The Actual EPS was $-0.13, which beat the estimate of $-0.14.
The Actual Revenue was $578K, which missed the estimate of $910K.
Browse earnings estimates, EPS, and revenue on all stocks.